Top

Published in:

01-12-2012 | Original Paper

Cognitive Deficits in Machado–Joseph Disease Correlate with Hypoperfusion of Visual System Areas

Authors: Pedro Braga-Neto, Lívia Almeida Dutra, José Luiz Pedroso, André C. Felício, Helena Alessi, Ruth F. Santos-Galduroz, Paulo Henrique F. Bertolucci, Mário Luiz V. Castiglioni, Rodrigo Affonseca Bressan, Griselda Esther Jara de Garrido, Orlando Graziani Povoas Barsottini, Andrea Jackowski

Published in: The Cerebellum | Issue 4/2012

Abstract

Cognitive and olfactory impairments have previously been demonstrated in patients with spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease (MJD)—SCA3/MJD. We investigated changes in regional cerebral blood flow (rCBF) using single-photon emission computed tomography (SPECT) imaging in a cohort of Brazilian patients with SCA3/MJD. The aim of the present study was to evaluate the correlation among rCBF, cognitive deficits, and olfactory dysfunction in SCA3/MJD. Twenty-nine genetically confirmed SCA3/MJD patients and 25 control subjects were enrolled in the study. The severity of cerebellar symptoms was measured using the International Cooperative Ataxia Rating Scale and the Scale for the Assessment and Rating of Ataxia. Psychiatric symptoms were evaluated by the Hamilton Anxiety Scale and Beck Depression Inventory. The neuropsychological assessment consisted of Spatial Span, Symbol Search, Picture Completion, the Stroop Color Word Test, Trail Making Test (TMT), and Phonemic Verbal Fluency. Subjects were also submitted to odor identification evaluation using the 16-item Sniffin’ Sticks. SPECT was performed using ethyl cysteine dimer labeled with technetium-99m. SCA3/MJD patients showed reduced brain perfusion in the cerebellum, temporal, limbic, and occipital lobes compared to control subjects (pFDR <0.001). A significant positive correlation was found between the Picture Completion test and perfusion of the left parahippocampal gyrus and basal ganglia in the patient group as well as a negative correlation between the TMT part A and bilateral thalamus perfusion. The visuospatial system is affected in patients with SCA3/MJD and may be responsible for the cognitive deficits seen in this disease.

Leiner HC, Leiner AL, Dow RS. Does the cerebellum contribute to mental skills? Behav Neurosci. 1986;100:443–54.PubMedCrossRef

Schmahmann JD. An emerging concept. The cerebellar contribution to higher function. Arch Neurol. 1991;48:1178–87.PubMedCrossRef

Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–79.PubMedCrossRef

Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. NeuroImage. 2009;44:489–501.PubMedCrossRef

Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex. 2010;46:831–44.PubMedCrossRef

Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.PubMedCrossRef

Lima L, Coutinho P. Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorean Portuguese family. Neurology. 1980;30:319–22.PubMedCrossRef

Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol. 2001;58:899–904.PubMedCrossRef

Braga-Neto P, Felicio AC, Pedroso JL, Dutra LA, Bertolucci PHF, Gabbai AA, et al. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2011;17:353–6.PubMedCrossRef

10.

Pedroso JL, Braga-Neto P, Felício AC, Dutra LA, Santos WAC, Do Prado GF, et al. Sleep disorders in Machado–Joseph disease: frequency, discriminative thresholds, predictive values and correlation with ataxia-related motor and non-motor features. Cerebellum. 2011;10:291–5.PubMedCrossRef

11.

Radvany J, Camargo CHP, Costa ZM, Fonseca NC, Nascimento ED. Machado Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the Catarina kindred. Arq Neuropsiquiatr. 1993;51:21–30.PubMedCrossRef

12.

Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250:207–11.PubMedCrossRef

13.

Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010;9:433–42.PubMedCrossRef

14.

Zawacki TM, Grace J, Friedman JH, Sudarsky L. Executive and emotional dysfunction in Machado-Joseph disease. Mov Disord. 2002;17:1004–10.PubMedCrossRef

15.

Maruff P, Tyler P, Burt T, Currie B, Burns C, Currie J. Cognitive deficits in Machado-Joseph disease. Ann Neurol. 1996;40:421–7.PubMedCrossRef

16.

Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G. Cognitive impairments in Machado-Joseph disease. Arch Neurol. 2004;61:1757–60.PubMedCrossRef

17.

Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Felício AC, Minett T, et al. (2012) Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. Cerebellum. doi:10.1007/s12311-011-0318-6

18.

Manto M, Lorivel T. Cognitive repercussions of hereditary cerebellar disorders. Cortex. 2011;47:81–10.PubMedCrossRef

19.

Abele M, Riet A, Hummel T, Klockgether T, Wüllner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol. 2003;250:1453–5.PubMedCrossRef

20.

Connelly T, Farmer JM, Lynch DR, Doty RL. Olfactory dysfunction in degenerative ataxias. J Neurol Neurosurg Psychiatr. 2003;74:1435–7.PubMedCrossRef

21.

Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP, Ochoa NC, Cruz GS, et al. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol. 2006;253:1165–9.PubMedCrossRef

22.

Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003;18(4):364–72.PubMedCrossRef

23.

Takahashi N, Odano I, Nishihara M, Yuasa T, Sakai K. Regional cerebral blood flow measured with N-isopropyl-p-[123I]iodoamphetamine single-photon emission tomography in patients with Joseph disease. Eur J Nucl Med. 1994;21:615–20.PubMedCrossRef

24.

Etchebehere EC, Cendes F, Lopes-Cendes I, Pereira JA, Lima MC, Sansana CR, et al. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol. 2001;58:1257–63.PubMedCrossRef

25.

Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome: the Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145:205–11.PubMedCrossRef

26.

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.PubMedCrossRef

27.

Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.PubMedCrossRef

28.

Wechsler D. Wechsler memory scale–revised manual. San Antonio: Psychological Corporation; 1987.

29.

Wechsler D. Wechsler adult intelligence scale, 3rd edition (WAIS III): test manual. 3rd ed. New York: The Psychological Corporation; 1997.

30.

Weschsler D. WAIS-III: Escala de inteligência para adultos: Manual para administração e avaliação. 1st ed. São Paulo: Casa do Psicólogo; 2004.

31.

Spreen O, Strauss E. A compendium of neuropsychological tests. 2nd ed. New York: Oxford University Press; 1998.

32.

Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Motor Skill. 1958;8:271–6.

33.

Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 2004.

34.

Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, Petrie A, Ranvaud R, Barbosa ER, et al. The use of smell identification tests in diagnosis of Parkinson’s disease in Brazil. Mov Disord. 2008;23:2328–34.PubMedCrossRef

35.

Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839–51.

36.

Rüb U, Brunt ER, Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado Joseph disease). Curr Opin Neurol. 2008;21:111–6.PubMedCrossRef

37.

Paulson HL, Das SS, Crino PB, Perez MK, Patel SC, Gotsdiner D, et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol. 1997;41:453–62.PubMedCrossRef

38.

Yamada M, Hayashi S, Tsuji S, Takahashi H. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease. Acta Neuropathol. 2001;101:140–4.PubMed

39.

D'Abreu A, França Jr MC, Yasuda CL, Campos BA, Lopes-Cendes I, Cendes F. Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study. J Neuroimaging. 2012. doi:10.1111/j.1552-6569.2011.00614.x

40.

Leh SE, Petrides M, Strafella AP. The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology. 2010;35:70–85.PubMedCrossRef

41.

Kravitz DJ, Saleem KS, Baker CI, Mishkin M. A new neural framework for visuospatial processing. Nat Rev Neurosci. 2011;12:217–30.PubMedCrossRef

42.

Possin KL. Visual spatial cognition in neurodegenerative disease. Neurocase. 2010;16:466–87.PubMedCrossRef

43.

Doeller CF, Kaplan R. Parahippocampal cortex: translating vision into space. Curr Biol. 2011;21(15):R589–91.PubMedCrossRef

44.

Macevoy SP, Epstein RA. Constructing scenes from objects in human occipitotemporal cortex. Nat Neurosci. 2011;14:1323–9.PubMedCrossRef

45.

Schmahmann JD, Pandya DN. Disconnection syndromes of basal ganglia, thalamus and cerebrocerebellar systems. Cortex. 2008;44:1037–66.PubMedCrossRef

46.

Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn. 2000;42:183–200.PubMedCrossRef

47.

Bostan AC, Strick PL. The cerebellum and basal ganglia are interconnected. Neuropsychol Rev. 2010;20:261–70.PubMedCrossRef

48.

Rüb U, de Vos RA, Brunt ER, Sebestény T, Schöls L, Auburger G, et al. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Brain Pathol. 2006;16:218–27.PubMedCrossRef

49.

De Oliveira MS, D'Abreu A, França Jr MC, Lopes-Cendes I, Cendes F, Castellano G. MRI-Texture analysis of corpus callosum, thalamus, putamen, and caudate in Machado-Joseph disease. J Neuroimaging. 2012. doi:10.1111/j.1552-6569.2010.00553.x

50.

Crowe SF. The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the Trail Making Test. J Clin Psychol. 1998;54:585–91.PubMedCrossRef

51.

Tanaka M, Kunimatsu J. Contribution of the central thalamus to the generation of volitional saccades. Eur J Neurosci. 2011;33:2046–57.PubMedCrossRef

52.

Saalmann YB, Kastner S. Cognitive and perceptual functions of the visual thalamus. Neuron. 2011;28(71):209–23.CrossRef

53.

Molinari M, Leggio MG. Cerebellar information processing and visuospatial functions. Cerebellum. 2007;6:214–20.PubMedCrossRef

54.

Meyer JS, Obara K, Muramatsu K. Diaschisis. Neurol Res. 1993;15:362–6.PubMed

55.

Kim YT, Shin SM, Lee WY, Kim GM, Jin DK. Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila). Cell Mol Neurobiol. 2004;24:109–22.PubMedCrossRef

56.

Goti D, Katzen SM, Mez J, Kurtis N, Kiluk J, Ben-Haïem L, et al. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci. 2004;24:10266–79.PubMedCrossRef

57.

Sobel N, Prabhakaran V, Hartley CA, Desmond JE, Zhao Z, Glover GH, et al. Odorant-induced and sniff-induced activation in the cerebellum of the human. J Neurosci. 1998;18(21):8990–9001.PubMed

58.

Qureshy A, Kawashima R, Imran MB, Sugiura M, Goto R, Okada K, Inoue K, et al. Functional mapping of human brain in olfactory processing: a PET study. J Neurophysiol. 2000;84:1656–66.PubMed

Title: Cognitive Deficits in Machado–Joseph Disease Correlate with Hypoperfusion of Visual System Areas
Authors: Pedro Braga-Neto
Lívia Almeida Dutra
José Luiz Pedroso
André C. Felício
Helena Alessi
Ruth F. Santos-Galduroz
Paulo Henrique F. Bertolucci
Mário Luiz V. Castiglioni
Rodrigo Affonseca Bressan
Griselda Esther Jara de Garrido
Orlando Graziani Povoas Barsottini
Andrea Jackowski
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: The Cerebellum / Issue 4/2012
Print ISSN: 1473-4222
Electronic ISSN: 1473-4230
DOI: https://doi.org/10.1007/s12311-012-0354-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cognitive Deficits in Machado–Joseph Disease Correlate with Hypoperfusion of Visual System Areas

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Asymptomatic Remote Cerebellar Hemorrhage: CT and MRI Findings

Friedreich's Ataxia Causes Redistribution of Iron, Copper, and Zinc in the Dentate Nucleus

Characterizing POLG Ataxia: Clinics, Electrophysiology and Imaging

Altered White Matter Structure of the Dentatorubrothalamic Pathway in Children with Autistic Spectrum Disorders

Cutaneous Sympathetic Dysfunction in Patients with Machado–Joseph Disease

Sex-Dependent Behavioral Functions of the Purkinje Cell-Specific Gαi/o Binding Protein, Pcp2(L7)